New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification
- PMID: 1515985
- DOI: 10.1002/1097-0142(19920901)70:5<1102::aid-cncr2820700514>3.0.co;2-5
New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification
Abstract
Background and methods: To validate the new TNM definitions for lung cancer (International Union Against Cancer [UICC] TNM classification, 4th edition, 1987), the data of 3823 patients were analyzed prospectively in terms of concordance between clinical (TNM) and pathologically confirmed classification (pTNM), the value of the various diagnostic techniques in estimating the pathologically confirmed classification, and the prognostic relevance of the new TNM definitions.
Results: With regard to the primary tumor (T), clinical and pathologic classifications were identical in 63%; with regard to lymph node involvement (N), the agreement was 47%; for distant metastasis agreement occurred in 91% of cases and for the stages it occurred in 56%. As to the primary tumor (T), the accuracy of radiography (59%) was nearly identical to that of computed tomography (CT) (58%). Both techniques were less precise in determining the extent of lymph node involvement (CT, correct assessments in 50%; radiography, correct assessments in 43%). The statistically significant differences in the prognosis for the T, N, and M categories and for the stages and the categories of the new R classification could be confirmed. Allowance should be made for the different prognosis between T1N0M0 and T2N0M0 by the new Substages IA and Ib of Stage I.
Conclusions: By the new TNM definitions for bronchus carcinoma, international conformity became feasible and practical, and the improvement of its prognostic relevance provided a more reliable basis for establishing guidelines for individual oncologic concepts.
Similar articles
-
Classification of lung cancer: first experiences with the new TNM classification (4th edition).Eur Respir J. 1991 Nov;4(10):1197-206. Eur Respir J. 1991. PMID: 1804667
-
Validation of the TNM classification (4th edn) for lung cancer: first results of a prospective study of 1086 patients with surgical treatment.Eur J Cardiothorac Surg. 1991;5(7):356-62. doi: 10.1016/1010-7940(91)90052-l. Eur J Cardiothorac Surg. 1991. PMID: 1892663
-
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.J Thorac Oncol. 2016 Mar;11(3):300-11. doi: 10.1016/j.jtho.2015.10.008. Epub 2015 Dec 24. J Thorac Oncol. 2016. PMID: 26723244
-
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.Eur Urol. 2018 Apr;73(4):560-569. doi: 10.1016/j.eururo.2017.12.018. Epub 2018 Jan 9. Eur Urol. 2018. PMID: 29325693 Review.
-
Staging of non-small cell lung cancer (NSCLC): a review.Respir Med. 2010 Dec;104(12):1767-74. doi: 10.1016/j.rmed.2010.08.005. Epub 2010 Sep 15. Respir Med. 2010. PMID: 20833010 Review.
Cited by
-
Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.Thorax. 2003 Mar;58(3):266-71. doi: 10.1136/thorax.58.3.266. Thorax. 2003. PMID: 12612310 Free PMC article. Review.
-
Systematic evaluation of PAXgene® tissue fixation for the histopathological and molecular study of lung cancer.J Pathol Clin Res. 2020 Jan;6(1):40-54. doi: 10.1002/cjp2.145. Epub 2019 Nov 11. J Pathol Clin Res. 2020. PMID: 31571426 Free PMC article.
-
Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.Ont Health Technol Assess Ser. 2010;10(24):1-48. Epub 2010 Dec 1. Ont Health Technol Assess Ser. 2010. PMID: 23074402 Free PMC article.
-
Clinical application of positron emission tomography in designing radiation fields in non-small cell lung cancer patients.Exp Ther Med. 2010 Nov;1(6):1027-1033. doi: 10.3892/etm.2010.153. Epub 2010 Sep 29. Exp Ther Med. 2010. PMID: 22993636 Free PMC article.
-
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.Br J Cancer. 2000 Aug;83(4):473-9. doi: 10.1054/bjoc.2000.1287. Br J Cancer. 2000. PMID: 10945494 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials